Related Experiment Video
Updated: Mar 24, 2026

07:22
Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease
Published on: November 8, 2017
10.8K
Blood-brain barrier dysfunction predicts cognitive trajectory after ischemic stroke
Biorxiv : the Preprint Server for Biology
|March 23, 2026
Summary
Chronic stroke survivors show blood-brain barrier dysfunction, linked to cognitive decline. This dysfunction may be a key mechanism driving dementia after stroke, offering new biomarker and treatment targets.
Area of Science:
- Neuroscience
- Vascular Biology
- Biomarkers
Background:
- Ischemic stroke significantly increases dementia risk, but the underlying mechanisms for late-stage cognitive decline remain unclear.
- While early cognition is affected by stroke severity, late dementia risk is not associated with infarct characteristics or stroke prevention.
- Existing research lacks understanding of the chronic mechanisms linking stroke to dementia.
Purpose of the Study:
- To investigate the role of chronic blood-brain barrier (BBB) dysfunction in cognitive decline following ischemic stroke.
- To identify proteomic, imaging, and structural biomarkers associated with post-stroke dementia.
- To explore potential therapeutic targets for preventing or treating cognitive impairment after stroke.
Main Methods:
- Plasma proteomic analysis was performed on stroke survivors and healthy controls to identify stroke-specific signatures.
- Longitudinal cognitive assessments (processing speed/executive function) were conducted over two years.
- Dynamic contrast-enhanced MRI was used to quantify BBB leakage in a cohort of stroke patients.
- Autopsy brain tissue analysis compared vascular mural cell coverage in individuals with and without post-stroke dementia.
Main Results:
- A distinct plasma proteomic signature associated with chronic stroke and BBB dysfunction was identified, including decreased platelet-derived growth factor B.
- This stroke-specific proteome was more pronounced in survivors experiencing cognitive decline in processing speed and executive function.
- Stroke survivors exhibited significantly higher whole-brain BBB leakage (1.7-fold) compared to controls.
- Individuals who died with dementia post-stroke showed a marked reduction in vascular mural cell coverage compared to those without dementia.
Conclusions:
- Chronic blood-brain barrier dysfunction is implicated as a key mechanism in late cognitive decline after ischemic stroke.
- Proteomic and imaging findings suggest potential biomarkers for identifying individuals at risk of post-stroke dementia.
- The study highlights vascular mural cell integrity and BBB function as critical factors and potential therapeutic targets for intervention.

